Anti-MDA5 DM is a systemic autoimmune disease that can be divided into 3 clinical subgroups, with different prognosis, linked to the incidence of RP-ILD which is influenced by the ethnic origin of the patients. Here, IFIH1 is linked to interstitial lung disease.